4Improper plate washing may lead to inaccurate results
manufacturer recommends against use) Women with a documented hypersensitivity reaction to semaglutide or tirzepatide excipients These restrictions appear directly in FDA-approved labeling and are not at the discretion of a telehealth clinician
Clinical approach considerations: Patient selection: Stable post-surgical patients with inadequate weight loss, weight regain, or persistent metabolic disease Timing: Individualized based on weight trajectory and metabolic status, often when weight loss plateaus or regain is documented Baseline evaluation: Comprehensive metabolic panel, nutritional markers (vitamin B12, iron studies, vitamin D, calcium, albumin), HbA1c if diabetic, lipid panel, assessment of gastrointestinal symptoms, renal function Dosing strategy: For Wegovy, initiate at 0.25 mg weekly with gradual titration (0.250.51.01.72.4 mg)
It modulates lipid metabolism, influencing the balance between HDL and LDL cholesterol
Women using oral contraceptives should use additional contraception for 4 weeks after starting Zepbound and with each dose increase
During these consultations, you can openly discuss any side effects, including nausea, and explore appropriate management strategies
